<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02975856</url>
  </required_header>
  <id_info>
    <org_study_id>VINOFLAVO_02</org_study_id>
    <nct_id>NCT02975856</nct_id>
  </id_info>
  <brief_title>Bioavailability of Red Wine Anthocyanins</brief_title>
  <official_title>Bioavailability of Table Red Wine and Young Port Red Wine Anthocyanins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade do Porto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>REQUIMTE/LAQV, Departamento de Química e Bioquímica, FCUP</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Center for Health Technology and Services Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vinoflavo</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade do Porto</source>
  <brief_summary>
    <textblock>
      The main aim of this study is to evaluate the bioavailability of table red wine and young&#xD;
      Port red wine anthocyanins in healthy men.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anthocyanins (ANT) are water soluble pigments found in plants, flowers and fruits that are&#xD;
      consumed as part of the human diet, many times in higher amounts than other flavonoid&#xD;
      classes. Red wine is also an important source of anthocyanins, especially Mv3glc.&#xD;
&#xD;
      Several epidemiological studies have suggested that the consumption of anthocyanin-rich&#xD;
      foods, including the moderate consumption of red wine, is positively associated with the&#xD;
      prevention of cardiovascular heart disease.&#xD;
&#xD;
      It has become clear that the flavonoid bioactive forms in vivo are not necessarily those&#xD;
      which occur in nature, but metabolites arising after absorption takes place.Therefore,&#xD;
      studying the bioavailability of red wine ANT is very important to identify which metabolites&#xD;
      (originated in vivo) can actually reach the target organs (and in which concentrations) and&#xD;
      may be responsible for the postulated health benefits of red wine.&#xD;
&#xD;
      Intervention protocol:&#xD;
&#xD;
      Urine samples and peripheral venous blood (10 ml) will be collected from 10 h-fasting&#xD;
      subjects. Afterwards, each volunteer will consume 250 ml of table red wine or 150 ml of young&#xD;
      Port red wine and blood samples will be collected 15, 30, 60 and 120 min after wines&#xD;
      ingestion. Another urine sample will be collected at 120 min.&#xD;
&#xD;
      Table red wine 12 % (250 ml) and young Port red wine 20 % (150 ml), two different food&#xD;
      matrices rich in ANT, provided the same amount of ethanol (24 g of ethanol).&#xD;
&#xD;
      A thorough screening analysis for ANT will be performed in plasma and urine samples collected&#xD;
      from the volunteers at different time points.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma concentrations of anthocyanins and anthocyanins metabolites</measure>
    <time_frame>At baseline and 15, 30, 60 and 120 minutes after wines consumption</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary concentrations of anthocyanins and anthocyanins metabolites</measure>
    <time_frame>At baseline and 120 minutes after wines consumption</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Table Red Wine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>250 ml Table Red Wine (12% ethanol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Port Red Wine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>150 ml Young Port Red Wine (20% ethanol)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Table Red Wine</intervention_name>
    <arm_group_label>Table Red Wine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Young Port Red Wine</intervention_name>
    <arm_group_label>Young Port Red Wine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men&#xD;
&#xD;
          -  Age 18-65 years&#xD;
&#xD;
          -  BMI &lt; 25 kg/m2&#xD;
&#xD;
          -  Willing and able to provide written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with current or previous CVD, diabetes or other severe chronic disease&#xD;
&#xD;
          -  Subjects under prescription of any chronic medication&#xD;
&#xD;
          -  Intake of red fruits or red wine in the last 24 h prior to the beginning of the&#xD;
             intervention&#xD;
&#xD;
          -  Subjects involved in any clinical or food study within the preceding month&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Conceição Calhau, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CINTESIS - Faculty of Medicine of University of Porto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CINTESIS - Faculty of Medicine of the University of Porto</name>
      <address>
        <city>Porto</city>
        <zip>4200-450</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>November 23, 2016</study_first_submitted>
  <study_first_submitted_qc>November 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2016</study_first_posted>
  <last_update_submitted>November 23, 2016</last_update_submitted>
  <last_update_submitted_qc>November 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anthocyanins</keyword>
  <keyword>Bioavailability</keyword>
  <keyword>Flavonoids</keyword>
  <keyword>Port wine</keyword>
  <keyword>Red wine</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

